News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
300,076 Results
Type
Article (16710)
Company Profile (300)
Press Release (283060)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (83074)
Career Advice (187)
Deals (13891)
Drug Delivery (40)
Drug Development (53049)
Employer Resources (33)
FDA (6942)
Job Trends (5543)
News (152867)
Policy (11070)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1001)
Accelerated approval (20)
Adcomms (16)
Allergies (83)
Alliances (22610)
ALS (125)
Alzheimer's disease (1035)
Antibody-drug conjugate (ADC) (243)
Approvals (7148)
Artificial intelligence (262)
Autoimmune disease (113)
Automation (9)
Bankruptcy (110)
Best Places to Work (4904)
BIOSECURE Act (6)
Biosimilars (115)
Biotechnology (230)
Bladder cancer (102)
Brain cancer (46)
Breast cancer (353)
Cancer (3229)
Cardiovascular disease (242)
Career advice (168)
Career pathing (8)
CAR-T (233)
CDC (6)
Cell therapy (591)
Cervical cancer (14)
Clinical research (45765)
Collaboration (1169)
Company closure (2)
Compensation (614)
Complete response letters (39)
COVID-19 (1115)
CRISPR (88)
C-suite (559)
Cystic fibrosis (113)
Data (4478)
Decentralized trials (1)
Denatured (15)
Depression (92)
Diabetes (258)
Diagnostics (1463)
Digital health (10)
Diversity (6)
Diversity, equity & inclusion (11)
Drug discovery (189)
Drug pricing (48)
Drug shortages (4)
Duchenne muscular dystrophy (214)
Earnings (33059)
Editorial (25)
Employer branding (4)
Employer resources (32)
Events (53770)
Executive appointments (627)
FDA (8820)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (999)
Gene editing (184)
Generative AI (21)
Gene therapy (497)
GLP-1 (523)
Government (1253)
Grass and pollen (3)
Guidances (184)
Healthcare (7341)
HIV (22)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (191)
Immuno-oncology (39)
Indications (69)
Infectious disease (1220)
Inflammatory bowel disease (157)
Inflation Reduction Act (10)
Influenza (39)
Intellectual property (170)
Interviews (27)
IPO (7532)
IRA (12)
Job creations (904)
Job search strategy (143)
JPM (42)
Kidney cancer (9)
Labor market (22)
Layoffs (245)
Leadership (10)
Legal (1570)
Liver cancer (45)
Longevity (11)
Lung cancer (424)
Lymphoma (267)
Machine learning (25)
Management (8)
Manufacturing (385)
MASH (130)
Medical device (3559)
Medtech (3576)
Mergers & acquisitions (6990)
Metabolic disorders (742)
Multiple sclerosis (103)
NASH (13)
Neurodegenerative disease (231)
Neuropsychiatric disorders (71)
Neuroscience (1961)
Neurotech (1)
NextGen: Class of 2026 (2217)
Non-profit (991)
Now hiring (31)
Obesity (340)
Opinion (127)
Ovarian cancer (132)
Pain (111)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (12)
Patents (309)
Patient recruitment (334)
Peanut (44)
People (27504)
Pharmaceutical (45)
Pharmacy benefit managers (6)
Phase 1 (15951)
Phase 2 (21048)
Phase 3 (13715)
Pipeline (3390)
Policy (90)
Postmarket research (1005)
Preclinical (6741)
Press Release (30)
Prostate cancer (155)
Psychedelics (50)
Radiopharmaceuticals (239)
Rare diseases (679)
Real estate (1522)
Recruiting (12)
Regulatory (10767)
Reports (20)
Research institute (1099)
Resumes & cover letters (21)
Rett syndrome (24)
RNA editing (21)
RSV (17)
Schizophrenia (123)
Series A (183)
Series B (135)
Service/supplier (1)
Sickle cell disease (85)
Special edition (18)
Spinal muscular atrophy (122)
Sponsored (15)
Startups (2063)
State (1)
Stomach cancer (5)
Supply chain (35)
Tariffs (18)
The Weekly (62)
Vaccines (349)
Venture capital (69)
Weight loss (179)
Women's health (27)
Worklife (2)
Date
Last 7 days (355)
Last 30 days (1258)
Last 365 days (18453)
2026 (1713)
2025 (18740)
2024 (21306)
2023 (23228)
2022 (28221)
2021 (29205)
2020 (24633)
2019 (17507)
2018 (12738)
2017 (14770)
2016 (12800)
2015 (15395)
2014 (11172)
2013 (8141)
2012 (8226)
2011 (8399)
2010 (8076)
Location
Africa (166)
Alabama (71)
Alaska (2)
Arizona (79)
Arkansas (6)
Asia (19150)
Australia (3276)
California (7301)
Canada (1864)
China (778)
Colorado (259)
Connecticut (260)
Delaware (243)
Europe (41490)
Florida (990)
Georgia (214)
Hawaii (2)
Idaho (21)
Illinois (425)
India (35)
Indiana (184)
Iowa (11)
Japan (232)
Kansas (81)
Kentucky (10)
Louisiana (7)
Maine (11)
Maryland (772)
Massachusetts (5691)
Michigan (113)
Minnesota (251)
Mississippi (3)
Missouri (33)
Montana (18)
Nebraska (5)
Nevada (33)
New Hampshire (21)
New Jersey (1727)
New Mexico (14)
New York (1828)
North Carolina (852)
North Dakota (6)
Northern California (3614)
Ohio (181)
Oklahoma (11)
Oregon (24)
Pennsylvania (1311)
Puerto Rico (9)
Rhode Island (26)
South America (242)
South Carolina (9)
Southern California (2868)
Tennessee (44)
Texas (955)
United States (24178)
Utah (100)
Virginia (144)
Washington D.C. (38)
Washington State (598)
West Virginia (1)
Wisconsin (45)
300,076 Results for "bone therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cerapedics’ PearlMatrix P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator, Now Approved for Expanded Indications for Use
January 14, 2026
·
6 min read
Press Releases
FDA Greenlights RevBio’s Pivotal Clinical Trial for its Cranial Flap Bone Glue
January 29, 2026
·
3 min read
Press Releases
SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026
February 3, 2026
·
1 min read
Press Releases
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025
January 13, 2026
·
3 min read
Phase III
Ultragenyx Loses $1B in Market Value as Bone Drug Fails To Reduce Fractures
With a pair of Phase III trial flops, Ultragenyx will explore cost reductions as analysts turn attention to an upcoming Angelman syndrome readout.
January 2, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
January 8, 2026
·
4 min read
Press Releases
Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health
December 2, 2025
·
5 min read
Press Releases
Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months
December 24, 2025
·
3 min read
Press Releases
Zetagen Therapeutics to Present Preliminary Results from Phase 2 Clinical Trial Targeting Metastatic Breast Cancer to Bone at the 2025 San Antonio Breast Cancer Symposium
November 4, 2025
·
5 min read
Press Releases
RevBio® Receives Approval from FDA to Start a Dental Clinical Trial for its Regenerative Bone Glue
December 23, 2025
·
3 min read
1 of 30,008
Next
